Related to ELOVL5 proteins found in multicellular animals. Probably also involved in very long chain fatty acid biosynthesis in ER.. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4Q5G6
Term | Name | Level | Count |
---|---|---|---|
GO:0000038 | very long-chain fatty acid metabolic process | 5 | 2 |
GO:0006082 | organic acid metabolic process | 3 | 10 |
GO:0006629 | lipid metabolic process | 3 | 10 |
GO:0006631 | fatty acid metabolic process | 4 | 10 |
GO:0006633 | fatty acid biosynthetic process | 5 | 10 |
GO:0006643 | membrane lipid metabolic process | 4 | 2 |
GO:0006665 | sphingolipid metabolic process | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0008610 | lipid biosynthetic process | 4 | 10 |
GO:0009058 | biosynthetic process | 2 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016053 | organic acid biosynthetic process | 4 | 10 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 7 | 2 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 7 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 10 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 2 |
GO:0030497 | fatty acid elongation | 6 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 10 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 8 | 2 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 8 | 2 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0044249 | cellular biosynthetic process | 3 | 10 |
GO:0044255 | cellular lipid metabolic process | 3 | 10 |
GO:0044281 | small molecule metabolic process | 2 | 10 |
GO:0044283 | small molecule biosynthetic process | 3 | 10 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 10 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 10 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004312 | fatty acid synthase activity | 5 | 10 |
GO:0009922 | fatty acid elongase activity | 6 | 10 |
GO:0016740 | transferase activity | 2 | 10 |
GO:0016746 | acyltransferase activity | 3 | 10 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 10 |
GO:0102756 | very-long-chain 3-ketoacyl-CoA synthase activity | 5 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.467 |
CLV_NRD_NRD_1 | 361 | 363 | PF00675 | 0.470 |
CLV_PCSK_KEX2_1 | 308 | 310 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.478 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.261 |
DEG_MDM2_SWIB_1 | 192 | 200 | PF02201 | 0.414 |
DOC_MAPK_gen_1 | 350 | 359 | PF00069 | 0.527 |
DOC_MAPK_MEF2A_6 | 353 | 361 | PF00069 | 0.535 |
DOC_MAPK_RevD_3 | 289 | 304 | PF00069 | 0.339 |
DOC_PP1_RVXF_1 | 150 | 156 | PF00149 | 0.261 |
DOC_PP1_RVXF_1 | 159 | 166 | PF00149 | 0.315 |
DOC_PP1_RVXF_1 | 42 | 48 | PF00149 | 0.360 |
DOC_PP2B_LxvP_1 | 200 | 203 | PF13499 | 0.414 |
DOC_USP7_MATH_1 | 314 | 318 | PF00917 | 0.673 |
DOC_USP7_MATH_1 | 324 | 328 | PF00917 | 0.594 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.326 |
DOC_WW_Pin1_4 | 141 | 146 | PF00397 | 0.361 |
LIG_14-3-3_CanoR_1 | 59 | 64 | PF00244 | 0.359 |
LIG_Actin_WH2_2 | 262 | 277 | PF00022 | 0.422 |
LIG_BRCT_BRCA1_1 | 61 | 65 | PF00533 | 0.343 |
LIG_CaMK_CASK_1 | 265 | 271 | PF00069 | 0.456 |
LIG_CSL_BTD_1 | 267 | 270 | PF09270 | 0.414 |
LIG_deltaCOP1_diTrp_1 | 147 | 155 | PF00928 | 0.263 |
LIG_EH1_1 | 75 | 83 | PF00400 | 0.364 |
LIG_eIF4E_1 | 120 | 126 | PF01652 | 0.407 |
LIG_eIF4E_1 | 224 | 230 | PF01652 | 0.342 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.550 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.397 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.350 |
LIG_GBD_Chelix_1 | 108 | 116 | PF00786 | 0.456 |
LIG_IRF3_LxIS_1 | 123 | 128 | PF10401 | 0.414 |
LIG_LIR_Gen_1 | 118 | 127 | PF02991 | 0.371 |
LIG_LIR_Gen_1 | 181 | 186 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 206 | 217 | PF02991 | 0.278 |
LIG_LIR_Gen_1 | 262 | 270 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 118 | 123 | PF02991 | 0.371 |
LIG_LIR_Nem_3 | 181 | 185 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 262 | 267 | PF02991 | 0.383 |
LIG_MYND_1 | 70 | 74 | PF01753 | 0.332 |
LIG_PCNA_PIPBox_1 | 288 | 297 | PF02747 | 0.371 |
LIG_Pex14_1 | 253 | 257 | PF04695 | 0.456 |
LIG_Pex14_2 | 192 | 196 | PF04695 | 0.339 |
LIG_Pex14_2 | 53 | 57 | PF04695 | 0.356 |
LIG_PTB_Apo_2 | 299 | 306 | PF02174 | 0.460 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.400 |
LIG_SH2_CRK | 177 | 181 | PF00017 | 0.462 |
LIG_SH2_GRB2like | 71 | 74 | PF00017 | 0.328 |
LIG_SH2_SRC | 71 | 74 | PF00017 | 0.332 |
LIG_SH2_STAP1 | 209 | 213 | PF00017 | 0.332 |
LIG_SH2_STAP1 | 264 | 268 | PF00017 | 0.315 |
LIG_SH2_STAP1 | 276 | 280 | PF00017 | 0.261 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.315 |
LIG_SH2_STAT5 | 225 | 228 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.297 |
LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.306 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.419 |
LIG_SUMO_SIM_anti_2 | 167 | 174 | PF11976 | 0.414 |
LIG_TRAF2_1 | 270 | 273 | PF00917 | 0.306 |
LIG_TYR_ITIM | 82 | 87 | PF00017 | 0.456 |
LIG_UBA3_1 | 153 | 161 | PF00899 | 0.339 |
LIG_UBA3_1 | 170 | 174 | PF00899 | 0.341 |
MOD_CK1_1 | 102 | 108 | PF00069 | 0.444 |
MOD_CK1_1 | 207 | 213 | PF00069 | 0.456 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.414 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.371 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.315 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.315 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.458 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.339 |
MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.389 |
MOD_GlcNHglycan | 276 | 279 | PF01048 | 0.389 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.557 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.407 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.298 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.438 |
MOD_GSK3_1 | 320 | 327 | PF00069 | 0.654 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.339 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.325 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.347 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.315 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.540 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.361 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.358 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.475 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.255 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.372 |
MOD_NEK2_2 | 99 | 104 | PF00069 | 0.400 |
MOD_PKA_1 | 303 | 309 | PF00069 | 0.523 |
MOD_Plk_1 | 39 | 45 | PF00069 | 0.523 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.315 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.315 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.314 |
MOD_Plk_4 | 178 | 184 | PF00069 | 0.315 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.285 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.315 |
MOD_Plk_4 | 225 | 231 | PF00069 | 0.329 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.379 |
MOD_ProDKin_1 | 141 | 147 | PF00069 | 0.456 |
MOD_SUMO_for_1 | 349 | 352 | PF00179 | 0.513 |
MOD_SUMO_rev_2 | 272 | 277 | PF00179 | 0.378 |
MOD_SUMO_rev_2 | 352 | 360 | PF00179 | 0.569 |
TRG_DiLeu_BaEn_1 | 356 | 361 | PF01217 | 0.589 |
TRG_DiLeu_BaLyEn_6 | 89 | 94 | PF01217 | 0.435 |
TRG_ENDOCYTIC_2 | 120 | 123 | PF00928 | 0.400 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.317 |
TRG_ENDOCYTIC_2 | 209 | 212 | PF00928 | 0.381 |
TRG_ENDOCYTIC_2 | 224 | 227 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 264 | 267 | PF00928 | 0.414 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.345 |
TRG_ER_diArg_1 | 334 | 337 | PF00400 | 0.455 |
TRG_ER_diArg_1 | 58 | 61 | PF00400 | 0.418 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0C5PHQ7 | Tachysurus fulvidraco | 30% | 100% |
A0A0N0P994 | Leptomonas seymouri | 65% | 100% |
A0A0S4JCZ3 | Bodo saltans | 52% | 100% |
A0A0S4JH58 | Bodo saltans | 31% | 100% |
A0A0S4KMP5 | Bodo saltans | 48% | 100% |
A0A1X0NUJ4 | Trypanosomatidae | 54% | 100% |
A0A3Q8I9X8 | Leishmania donovani | 25% | 100% |
A0A3Q8IC05 | Leishmania donovani | 28% | 100% |
A0A3Q8IT78 | Leishmania donovani | 92% | 100% |
A0A3S7WT03 | Leishmania donovani | 26% | 100% |
A4H7M6 | Leishmania braziliensis | 27% | 100% |
A4HKA3 | Leishmania braziliensis | 78% | 100% |
A4HW12 | Leishmania infantum | 25% | 100% |
A4I7T3 | Leishmania infantum | 92% | 100% |
D4A612 | Rattus norvegicus | 30% | 100% |
E9AGL0 | Leishmania infantum | 26% | 100% |
E9APR9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9B2P1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q3S8M4 | Macaca mulatta | 32% | 100% |
Q4QFR5 | Leishmania major | 27% | 100% |
Q95K73 | Macaca fascicularis | 32% | 100% |
Q9EQC4 | Mus musculus | 30% | 100% |
Q9GZR5 | Homo sapiens | 33% | 100% |
Q9JLJ5 | Mus musculus | 31% | 100% |
Q9VHX7 | Drosophila melanogaster | 30% | 100% |